Physician profile
Shyama S Mathews
NPI 1598084238
$53,502.17
in general payments reported to CMS, 2019-2025
32 companies · $6,572 in 2025
The $6,572 reported for 2025 was more than what 94% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,832 · 2020: $274 · 2021: $9,351 · 2022: $13K · 2023: $2,467 · 2024: $20K · 2025: $6,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Travel and Lodging: $2,936 · Food and Beverage: $2,349 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,164.99 |
| Travel and Lodging | $2,935.81 |
| Food and Beverage | $2,349.41 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,285.53 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $21,715.31 | 2019-2023 | |
| Therapeuticsmd, INC. | $261.97 | 2019-2021 | |
| Novo Nordisk INC | $246.41 | 2019-2025 | Wegovy |
| Gynesonics, INC. | $211.69 | 2022 | |
| Medtronic, INC. | $199.34 | 2021-2025 | Sonicision, V-Loc 180 |
| Ethicon US, LLC | $183.91 | 2021-2024 | Stratafix |
| Baxter Healthcare | $171.21 | 2023-2024 | Starling System, Perclot |
| Millicent US INC | $161.09 | 2019-2025 | Intrarosa, Femring |
| Pfizer INC. | $122.15 | 2019-2024 | |
| Astellas Pharma US INC | $102.81 | 2024 | Veozah |
| Amag Pharmaceuticals, INC. | $97.67 | 2019-2020 | |
| Eisai INC. | $90.76 | 2019-2021 | |
| Coloplast Corp | $82.16 | 2019 | |
| Duchesnay USA Incorporated | $63.08 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $51.68 | 2019-2020 | |
| Allergan, INC. | $51.27 | 2019 | |
| Sumitomo Pharma America, INC. | $44.52 | 2023 | Myfembree |
| Daiichi Sankyo INC. | $42.66 | 2019-2020 | |
| Exeltis, USA INC. | $40.74 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.54 | 2020-2021 | |
| Lupin INC. | $35.27 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $32.59 | 2022-2023 | |
| Avion Pharmaceuticals | $28.82 | 2019 | |
| Agile Therapeutics, INC. | $27.92 | 2021 | |
| Aspira Women'S Health INC | $21.96 | 2020 | |
| Vivus LLC | $19.42 | 2019 | |
| Exact Sciences Corporation | $17.49 | 2023 | Cologuard Collection Kit |
| Ferring Pharmaceuticals INC. | $15.23 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.90 | 2019 | |
| Zyla Life Sciences, INC. | $14.77 | 2020 | |
| Coopersurgical, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shyama Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.